Mali

Mali

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
5 (3.90 - 5.96) 2019 Modelled IHME
4.96 (3.99 - 5.76) 2018 Modelled IHME
4.98 (4.10 - 5.75) 2017 Modelled IHME
5.15 (4.40 - 5.89) 2016 Modelled IHME
5.36 (4.54 - 6.23) 2015 Modelled IHME
5.46 (4.60 - 6.29) 2014 Modelled IHME
5.54 (4.67 - 6.35) 2013 Modelled IHME
5.61 (4.68 - 6.43) 2012 Modelled IHME
5.67 (4.73 - 6.52) 2011 Modelled IHME
5.74 (4.71 - 6.64) 2010 Modelled IHME
5.81 (4.81 - 6.69) 2009 Modelled IHME
5.88 (4.87 - 6.75) 2008 Modelled IHME
5.94 (4.98 - 6.85) 2007 Modelled IHME
6.02 (5.07 - 6.97) 2006 Modelled IHME
6.11 (5.16 - 7.11) 2005 Modelled IHME
6.24 (5.32 - 7.20) 2004 Modelled IHME
6.41 (5.46 - 7.36) 2003 Modelled IHME
6.59 (5.59 - 7.58) 2002 Modelled IHME
6.74 (5.70 - 7.80) 2001 Modelled IHME
6.81 (5.74 - 7.95) 2000 Modelled IHME
6.83 (5.73 - 7.95) 1999 Modelled IHME
6.84 (5.71 - 7.98) 1998 Modelled IHME
6.84 (5.66 - 8.04) 1997 Modelled IHME
6.83 (5.59 - 8.07) 1996 Modelled IHME
6.83 (5.54 - 8.11) 1995 Modelled IHME
6.83 (5.56 - 8.12) 1994 Modelled IHME
6.82 (5.57 - 8.06) 1993 Modelled IHME
6.81 (5.56 - 8.02) 1992 Modelled IHME
6.79 (5.55 - 7.97) 1991 Modelled IHME
6.78 (5.51 - 7.86) 1990 Modelled IHME
8.54 (6.48 - 11.06) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.33 (1.36 - 3.06) 2019 Modelled IHME
2.49 (1.47 - 3.22) 2018 Modelled IHME
2.57 (1.62 - 3.30) 2017 Modelled IHME
2.58 (1.81 - 3.23) 2016 Modelled IHME
2.57 (1.91 - 3.25) 2015 Modelled IHME
2.54 (1.90 - 3.15) 2014 Modelled IHME
2.49 (1.84 - 3.09) 2013 Modelled IHME
2.43 (1.76 - 3.02) 2012 Modelled IHME
2.37 (1.68 - 2.96) 2011 Modelled IHME
2.3 (1.59 - 2.92) 2010 Modelled IHME
2.23 (1.55 - 2.82) 2009 Modelled IHME
2.13 (1.49 - 2.69) 2008 Modelled IHME
2.03 (1.45 - 2.55) 2007 Modelled IHME
1.96 (1.41 - 2.48) 2006 Modelled IHME
1.93 (1.38 - 2.48) 2005 Modelled IHME
2.28 (1.68 - 2.90) 2004 Modelled IHME
3.12 (2.34 - 3.92) 2003 Modelled IHME
4.13 (3.14 - 5.17) 2002 Modelled IHME
4.99 (3.78 - 6.30) 2001 Modelled IHME
5.37 (4.06 - 6.85) 2000 Modelled IHME
5.41 (4.03 - 6.94) 1999 Modelled IHME
5.42 (3.94 - 7.03) 1998 Modelled IHME
5.43 (3.82 - 7.12) 1997 Modelled IHME
5.42 (3.76 - 7.17) 1996 Modelled IHME
5.42 (3.67 - 7.20) 1995 Modelled IHME
5.41 (3.72 - 7.14) 1994 Modelled IHME
5.4 (3.71 - 7.12) 1993 Modelled IHME
5.37 (3.70 - 7.02) 1992 Modelled IHME
5.34 (3.68 - 6.94) 1991 Modelled IHME
5.3 (3.70 - 6.81) 1990 Modelled IHME
4.88 (3.23 - 6.81) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
39 (30 - 49) 2019 Modelled IHME
39 (31 - 49) 2018 Modelled IHME
39 (30 - 49) 2017 Modelled IHME
39 (30 - 49) 2016 Modelled IHME
38 (30 - 48) 2015 Modelled IHME
38 (30 - 49) 2014 Modelled IHME
39 (30 - 49) 2013 Modelled IHME
39 (31 - 50) 2012 Modelled IHME
40 (31 - 50) 2011 Modelled IHME
40 (31 - 50) 2010 Modelled IHME
40 (31 - 50) 2009 Modelled IHME
40 (31 - 50) 2008 Modelled IHME
40 (32 - 50) 2007 Modelled IHME
40 (31 - 50) 2006 Modelled IHME
40 (31 - 50) 2005 Modelled IHME
40 (31 - 50) 2004 Modelled IHME
40 (32 - 50) 2003 Modelled IHME
40 (31 - 50) 2002 Modelled IHME
40 (31 - 49) 2001 Modelled IHME
39 (30 - 49) 2000 Modelled IHME
39 (31 - 49) 1999 Modelled IHME
39 (31 - 49) 1998 Modelled IHME
39 (31 - 49) 1997 Modelled IHME
39 (31 - 49) 1996 Modelled IHME
39 (31 - 49) 1995 Modelled IHME
39 (31 - 49) 1994 Modelled IHME
39 (31 - 49) 1993 Modelled IHME
39 (31 - 49) 1992 Modelled IHME
39 (31 - 49) 1991 Modelled IHME
39 (31 - 49) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
71 2018 Survey/reported WHO/UNICEF
70 2017 Survey/reported WHO/UNICEF
69 2016 Survey/reported WHO/UNICEF
67 2015 Survey/reported WHO/UNICEF
66 2014 Survey/reported WHO/UNICEF
64 2013 Survey/reported WHO/UNICEF
65 2012 Survey/reported WHO/UNICEF
66 2011 Survey/reported WHO/UNICEF
72 2010 Survey/reported WHO/UNICEF
71 2009 Survey/reported WHO/UNICEF
74 2008 Survey/reported WHO/UNICEF
74 2007 Survey/reported WHO/UNICEF
90 2006 Survey/reported WHO/UNICEF
83 2005 Survey/reported WHO/UNICEF
73 2004 Survey/reported WHO/UNICEF
79 2003 Survey/reported WHO/UNICEF
Showing out of
Show more

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HepB birth dose policy
No
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.86 (2.28 - 3.58) 2019 Modelled IHME
2.87 (2.30 - 3.57) 2018 Modelled IHME
2.88 (2.28 - 3.60) 2017 Modelled IHME
2.89 (2.32 - 3.61) 2016 Modelled IHME
2.9 (2.32 - 3.61) 2015 Modelled IHME
2.91 (2.35 - 3.62) 2014 Modelled IHME
2.94 (2.37 - 3.66) 2013 Modelled IHME
2.98 (2.39 - 3.72) 2012 Modelled IHME
3.02 (2.42 - 3.78) 2011 Modelled IHME
3.06 (2.44 - 3.84) 2010 Modelled IHME
3.09 (2.47 - 3.87) 2009 Modelled IHME
3.12 (2.50 - 3.92) 2008 Modelled IHME
3.16 (2.52 - 3.96) 2007 Modelled IHME
3.2 (2.54 - 3.99) 2006 Modelled IHME
3.24 (2.57 - 4.04) 2005 Modelled IHME
3.28 (2.61 - 4.08) 2004 Modelled IHME
3.33 (2.66 - 4.15) 2003 Modelled IHME
3.37 (2.71 - 4.21) 2002 Modelled IHME
3.42 (2.76 - 4.27) 2001 Modelled IHME
3.47 (2.79 - 4.32) 2000 Modelled IHME
3.52 (2.84 - 4.37) 1999 Modelled IHME
3.57 (2.89 - 4.45) 1998 Modelled IHME
3.62 (2.93 - 4.52) 1997 Modelled IHME
3.67 (2.95 - 4.57) 1996 Modelled IHME
3.7 (2.97 - 4.65) 1995 Modelled IHME
3.73 (3 - 4.65) 1994 Modelled IHME
3.76 (3.03 - 4.70) 1993 Modelled IHME
3.78 (3.04 - 4.72) 1992 Modelled IHME
3.8 (3.05 - 4.76) 1991 Modelled IHME
3.81 (3.06 - 4.77) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
31 (22 - 40) 2019 Modelled IHME
31 (22 - 40) 2018 Modelled IHME
31 (22 - 40) 2017 Modelled IHME
31 (22 - 40) 2016 Modelled IHME
32 (23 - 41) 2015 Modelled IHME
32 (23 - 41) 2014 Modelled IHME
32 (23 - 41) 2013 Modelled IHME
31 (23 - 40) 2012 Modelled IHME
31 (23 - 40) 2011 Modelled IHME
31 (23 - 40) 2010 Modelled IHME
31 (23 - 40) 2009 Modelled IHME
31 (23 - 40) 2008 Modelled IHME
31 (23 - 40) 2007 Modelled IHME
32 (23 - 40) 2006 Modelled IHME
32 (23 - 40) 2005 Modelled IHME
32 (23 - 40) 2004 Modelled IHME
32 (23 - 40) 2003 Modelled IHME
32 (23 - 40) 2002 Modelled IHME
32 (23 - 40) 2001 Modelled IHME
32 (23 - 40) 2000 Modelled IHME
32 (23 - 40) 1999 Modelled IHME
31 (23 - 40) 1998 Modelled IHME
31 (23 - 40) 1997 Modelled IHME
31 (23 - 40) 1996 Modelled IHME
31 (23 - 40) 1995 Modelled IHME
31 (23 - 40) 1994 Modelled IHME
31 (22 - 40) 1993 Modelled IHME
31 (22 - 40) 1992 Modelled IHME
31 (22 - 40) 1991 Modelled IHME
31 (22 - 40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HepB birth dose policy
No
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
5 (%)
2019
(3.9 - 5.96(%))
IHME
HCV (RNA/cAg+)
2.86 (%)
2019
(2.28 - 3.58(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
2,207
2019
(1,572 - 2,957)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
656
2019
(461 - 898)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
2.33 (%)
2019, latest modelled
(1.36 - 3.06(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners